Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

SelectScience Editorial Article: Insights into the UK’s Largest Independent Integrated Drug Discovery CRO

SelectScience recently interviewed Denise Swift, a Senior Bioscientist, Project and Team Leader at Sygnature Discovery.  Denise is responsible for evaluating new technologies to enhance Sygnature’s Bioscience capabilities – in particular, screening technologies, instrumentation and automation.

The interview highlighted Sygnature Discovery’s novel approach to custom assay development and revealed some of the secrets of our success in accelerating the discovery of new therapeutics.

The interview can be found here: http://www.selectscience.net/editorial-articles/insights-into-the-uks-largest-independent-integrated-drug-discovery-cro/?artID=43909

Latest News

View All

RenaSci’s Sharon Cheetham awarded BPS Fellowship

Sygnature Discovery invests in high-throughput screening capability

Sygnature Discovery moves US base to Kendall…

Sygnature Discovery raises over £2,776 for Cancer…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.